Literature DB >> 31630277

Ventricle-predominant primary CNS lymphomas: clinical, radiological and pathological evaluation of five cases and review of the literature.

Matthew K Ball1, Jonathan M Morris2, Adam J Wood3, Fredric B Meyer4, Megan C Kaszuba4, Aditya Raghunathan3.   

Abstract

Primary central nervous system lymphomas (PCNSLs) are typically intraparenchymal. A subset of PCNSLs predominantly arises in the ventricles, with minimal parenchymal involvement. We review the clinical, radiological, and pathological features of ventricle-predominant PCNSLs (VP-PCNSLs) in 40 previously reported cases and report 5 additional cases. Including all cases of VP-PCNSLs (n = 45), 38% were diffuse large B-cell lymphomas (DLBCL), 11% were Burkitt lymphomas, 7% were MALT lymphomas, 4% were T-cell lymphomas, and 40% were lymphomas, not otherwise classified. VP-PCNSLs show rapid clinical progression. Patients present at a median age of 60.5 years. Unique clinical and radiological features distinguish them from other intraventricular tumors, including advanced age, edema, multifocality, hyperdensity, early and avid post-contrast enhancement, restricted diffusion, and positron emission tomography (PET) hypermetabolism. Including our cases, which were all DLBCL, and all previously reported DLBCL cases (n = 10), 8 of 10 show germinal center B-cell-like (GCB) phenotype, contrasting the high prevalence of non-germinal center B-cell-like (non-GCB) phenotype of parenchymal DLBCL PCNSLs. MYD88 L265P mutation was detected in three of our five cases. Ventricle-predominant PCNSLs are clinically and radiologically distinct, and the DLBCLs may be pathologically distinct. Further recognition of this entity may help to evaluate the role of therapies, possibly including surgical resection.

Entities:  

Keywords:  B-cell lymphoma; Intraventricular tumor; Primary CNS lymphoma; Ventricle

Year:  2019        PMID: 31630277     DOI: 10.1007/s10014-019-00354-x

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  4 in total

Review 1.  Efficacy of endoscopic management of primary central nervous system lymphoma: a multicentric study and literature review.

Authors:  Mario Ganau; Ismail Zaed; Julien Todeschi; Laura Prisco; Helene Cebula; Carmen Bruno; Giorgio Spatola; Gianfranco K I Ligarotti; Raffaele Alessandrello; Marco Fricia; Antonio Romano; Raoul Pop; Seyyid Baloglu; Luciano Savarese; Antonino Scibilia; Beniamino Nannavecchia; Francois Proust; Salvatore Chibbaro
Journal:  J Neurooncol       Date:  2022-07-12       Impact factor: 4.506

Review 2.  Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development.

Authors:  Kensuke Tateishi; Yohei Miyake; Taishi Nakamura; Tetsuya Yamamoto
Journal:  Brain Tumor Pathol       Date:  2021-07-13       Impact factor: 3.298

3.  Primary intracranial marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the lateral ventricle: Case report and review of pathogenesis.

Authors:  Sabastian Hajtovic; Edward Yu; Alexander Bershadskiy; Raphael Sacho; Ronit Gilad
Journal:  Surg Neurol Int       Date:  2022-04-29

4.  Clinical Features, Diagnosis, and Treatment of Primary Intraventricular Lymphoma: Insights From a Monocentric Case Series.

Authors:  Lidong Cheng; Hongtao Zhu; Jing Wang; Guanghui Wang; Xiaoyu Ma; Kai Zhao; Junwen Wang; Kai Shu
Journal:  Front Neurol       Date:  2022-06-06       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.